Follow The Filings

ALT Altimmune

Altimmune earnings company data as of 4:00 PM ET 11/1

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS -0.14 — —
Rev — — —

Insider trades

Open-market buys and sales by ALT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ALT insider trades
  • $370K bought by 6 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Jerome Benedict Durso CEO
    Buy
    $44K 15,000 shares at $2.95 +32% to stake
    Traded Aug 13 Filed Aug 13
  2. John Gill Director
    Buy
    $31K 9,200 shares at $3.41 +74% to stake
    Traded Apr 6 Filed Apr 6
  3. Jerome Benedict Durso CEO
    Buy
    $47K 15,000 shares at $3.14 +46% to stake
    Traded Apr 1 Filed Apr 1
  4. Gregory L Weaver CFO
    Buy
    $31K 10,000 shares at $3.15 +36% to stake
    Traded Apr 1 Filed Apr 1
  5. Jerome Benedict Durso CEO
    Buy
    $71K 20,000 shares at $3.54 +160% to stake
    Traded Mar 6 Filed Mar 9
  6. Gregory L Weaver CFO
    Buy
    $18K 5,000 shares at $3.54 +22% to stake
    Traded Mar 6 Filed Mar 9
  7. Wayne Pisano Director
    Buy
    $20K 5,000 shares at $4.08 +59% to stake
    Traded Jan 8 Filed Jan 9
  8. Catherine A. Sohn Director
    Buy
    $2,118 500 shares at $4.24 +50% to stake
    Traded Jan 5 Filed Jan 5
  9. Diane Jorkasky Director
    Buy
    $2,003 527 shares at $3.80 New stake
    Traded Dec 29, 2025 Filed Dec 29, 2025
  10. John Gill Director
    Buy
    $51K 12,500 shares at $4.10 New stake
    Traded Dec 23, 2025 Filed Dec 23, 2025
  11. Jerome Benedict Durso Director
    Buy
    $52K 12,500 shares at $4.13 New stake
    Traded Dec 22, 2025 Filed Dec 22, 2025

Also filed in the last 12 months, not counted as buying or selling: 14 share withholdings for taxes, 14 option exercises, and 5 stock grants.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
8-K 2.03
8-K 5.02,7.01,9.01
8-K 5.02
8-K 2.02,9.01
10-Q
8-K 7.01,8.01,9.01
8-K 8.01
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G —
424B5
8-K 1.01,9.01
424B5
8-K 5.03,5.07,9.01
SCHEDULE 13G/A —
DEF 14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf